Professor Judson trained at Cambridge University and King’s College Hospital Medical School. His research initially focused on the development of new anticancer drugs, including both laboratory research and Phase I clinical trials.

In addition to new drug development, Professor Judson has specialised in the management of sarcomas for the past 25 years and has made a particular study of gastrointestinal stromal tumours (GIST). He was a principal investigator in the Phase I/II trial of imatinib for GIST in 2000/1 and has been actively involved in research into the treatment of this disease since that time.

Professor Judson has been chief investigator for many national and international sarcoma trials, has held senior positions in many important cancer research bodies and has more than 200 peer-reviewed research publications, in addition to numerous reviews, editorials and book chapters.

This talk will be held in lecture theatre B, Zoology department. Entry will be free for OU Biological Society members, and £3 for non-members